This article may be reprinted free of charge provided 1) that there is clear attribution to the Orthomolecular Medicine News Service, and 2) that both the OMNS free subscription link http://orthomolecular.org/subscribe.html and also the OMNS archive link http://orthomolecular.org/resources/omns/index.shtml are included.
FOR IMMEDIATE RELEASE
Orthomolecular Medicine News Service, September 16, 2016
NEWSWEEK Advocates Intravenous Vitamin C
50,000 to 100,000 milligrams a day "greatly arrests the activity of the cancer"
by Andrew W. Saul, Editor
(OMNS, Sept 16, 2016) You can't always judge a book by its cover, and that goes for magazines as well. The 6 Sept 2016 issue of Japan's edition of NEWSWEEK contains a very important, very positive article on intravenous vitamin C against cancer. IV vitamin C specialist Atsuo Yanagisawa, MD, PhD is spotlighted and his rationale, procedures and dosages are discussed in welcome detail. If you have a family member or friend who is fighting cancer, this article is essential reading. Just get past the cover and read the full text, translated into English, free of charge at http://www.doctoryourself.com/NewsweekSept06English.pdf This large file may take a while to download.
Dr. Yanagisawa says, "The vitamin C used in this treatment is highly concentrated and is given in 50- to 100-gram doses, which is the equivalent to 2,000 to 5,000 lemons directly introduced into a vein - not orally - but via an IV infusion, raising the vitamin C concentration in blood by a huge amount. More and more cases are using a combination of chemotherapy and high-dose IV vitamin C therapy. Using this therapy to assist other treatments reaps great results."
Furthermore, he adds: "We know that high-dose IV vitamin C therapy is very effective against just about all forms of cancer. A considerable number of patients say that pain has been greatly reduced. . . One person having trouble breathing due to lung cancer found that their coughing subsided after infusion, which surprised both the patient and the family."
So you can learn more, Newsweek has included a reference listing of over 20 recent and current research studies (page 53). The magazine's editorial stance is right on the mark: "We need to at least know about the existence of high-dose IV vitamin C therapy." By publishing this life-saving information, Japan's Newsweek has done all of us a favor.
Nutritional Medicine is Orthomolecular Medicine
Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org
Find a Doctor
To locate an orthomolecular physician near you: http://orthomolecular.org/resources/omns/v06n09.shtml
The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.
Editorial Review Board:
Ian Brighthope, M.D. (Australia)
Ralph K. Campbell, M.D. (USA)
Carolyn Dean, M.D., N.D. (USA)
Damien Downing, M.D. (United Kingdom)
Michael Ellis, M.D. (Australia)
Martin P. Gallagher, M.D., D.C. (USA)
Michael J. Gonzalez, N.M.D., D.Sc., Ph.D. (Puerto Rico)
William B. Grant, Ph.D. (USA)
Ron Hunninghake, M.D. (USA)
Michael Janson, M.D. (USA)
Robert E. Jenkins, D.C. (USA)
Bo H. Jonsson, M.D., Ph.D. (Sweden)
Peter H. Lauda, M.D. (Austria)
Thomas Levy, M.D., J.D. (USA)
Stuart Lindsey, Pharm.D. (USA)
Joseph Mercola, D.O. (USA)
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico)
Karin Munsterhjelm-Ahumada, M.D. (Finland)
W. Todd Penberthy, Ph.D. (USA)
Jeffrey A. Ruterbusch, D.O. (USA)
Gert E. Schuitemaker, Ph.D. (Netherlands)
Jagan Nathan Vamanan, M.D. (India)
Ken Walker, M.D. (Canada)
Atsuo Yanagisawa, M.D., Ph.D. (Japan)
Robert G. Smith, Ph.D. (USA), Assistant Editor
Helen Saul Case, M.S. (USA), Assistant Editor
Michael S. Stewart, B.Sc.C.S. (USA), Technology Editor
Andrew W. Saul, Ph.D. (USA), Editor and contact person. Email: firstname.lastname@example.org This is a comments-only address; OMNS is unable to respond to individual reader emails. However, readers are encouraged to write in with their viewpoints. Reader comments become the property of OMNS and may or may not be used for publication.
To Subscribe at no charge: http://www.orthomolecular.org/subscribe.html
To Unsubscribe from this list: http://www.orthomolecular.org/unsubscribe.html